Biofrontera (BFRI) Short Interest Ratio & Short Volume → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free BFRI Stock Alerts $1.54 -0.06 (-3.75%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Biofrontera Short Interest DataCurrent Short Volume44,000 sharesPrevious Short Volume34,800 sharesChange Vs. Previous Month+26.44%Dollar Volume Sold Short$72,160.00Short Interest Ratio / Days to Cover0.1Last Record DateApril 15, 2024Outstanding Shares5,090,000 sharesFloat Size3,670,000 sharesShort Percent of Float1.20%Today's Trading Volume35,796 sharesAverage Trading Volume580,229 sharesToday's Volume Vs. Average6% Short Selling Biofrontera ? Sign up to receive the latest short interest report for Biofrontera and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBFRI Short Interest Over TimeBFRI Days to Cover Over TimeBFRI Percentage of Float Shorted Over Time Ad Paradigm PressAI “wealth window” is closing June 25thToday, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.I put together this personal video [HERE]… Biofrontera Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202444,000 shares $72,160.00 +26.4%1.2%0.1 $1.64 3/31/202434,800 shares $53,592.00 -58.7%1.0%0 $1.54 3/15/202484,200 shares $130,510.00 -23.7%6.1%0.1 $1.55 2/29/2024110,300 shares $92,398.31 -59.0%10.7%0.2 $0.84 2/15/2024269,100 shares $186,674.67 +806.1%26.1%0.4 $0.69 1/31/202429,700 shares $39,501.00 -4.8%3.0%0.1 $1.33 Get the Latest News and Ratings for BFRI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Biofrontera and its competitors with MarketBeat's FREE daily newsletter. 1/15/202431,200 shares $68,952.00 +3.0%3.2%0.4 $2.21 12/31/202330,300 shares $83,931.00 -13.4%3.1%0.4 $2.77 12/15/202335,000 shares $103,600.00 -31.6%3.5%0.7 $2.96 11/30/202351,200 shares $171,325.44 -5.5%5.4%1.3 $3.35 11/15/202354,200 shares $203,792.00 -60.3%6.1%1.4 $3.76 10/31/2023136,400 shares $641,080.00 +662.0%17.2%3.6 $4.70 10/15/202317,900 shares $120,288.00 +2.9%2.3%0.5 $6.72 9/30/202317,400 shares $152,598.00 -17.1%2.2%1.2 $8.77 9/15/202321,000 shares $178,710.00 +9.4%2.7%1.3 $8.51 8/31/202319,200 shares $166,272.00 -22.9%2.5%0.8 $8.66 8/15/202324,900 shares $230,574.00 -3.5%3.2%1 $9.26 7/31/202325,800 shares $303,150.00 +46.6%0.2%1.1 $11.75 7/15/202317,600 shares $162,976.00 -21.8%0.1%0.7 $9.26 6/30/202322,500 shares $234,000.00 -92.9%0.2%1.5 $10.40 6/15/2023316,400 shares $134,470.00 +46.8%2.1%1.4 $0.43 5/31/2023215,600 shares $101,332.00 -20.4%1.4%2.8 $0.47 5/15/2023270,800 shares $109,674.00 +12.3%1.8%2.8 $0.41 4/30/2023241,200 shares $142,308.00 -8.5%1.6%2.9 $0.59 4/15/2023263,700 shares $156,901.50 -0.1%1.7%2.7 $0.60 3/31/2023263,900 shares $160,979.26 +20.1%1.7%2.5 $0.61 3/15/2023219,800 shares $137,550.84 -7.1%1.4%1.8 $0.63 2/28/2023236,500 shares $175,104.60 -8.8%1.9%1.9 $0.74 2/15/2023259,300 shares $212,496.35 -32.9%2.1%2.3 $0.82 1/31/2023386,200 shares $328,192.76 +3.5%3.1%3.4 $0.85 1/15/2023373,000 shares $372,627.00 -20.2%3.0%4 $1.00 12/30/2022467,400 shares $428,418.84 +17.3%3.7%4.3 $0.92 12/15/2022398,500 shares $354,665.00 -24.9%3.2%3.2 $0.89 11/30/2022530,800 shares $557,340.00 -8.1%4.8%3.7 $1.05 11/15/2022577,500 shares $589,050.00 +6.9%5.2%2.4 $1.02 10/31/2022540,500 shares $583,740.00 +25.3%4.7%1.5 $1.08 10/15/2022431,500 shares $522,115.00 +61.0%3.8%1 $1.21 9/30/2022268,100 shares $281,505.00 +35.3%2.3%0.4 $1.05 9/15/2022198,200 shares $225,948.00 -29.4%1.7%0.3 $1.14 8/31/2022280,600 shares $325,496.00 -17.0%2.8%0.4 $1.16Tech GIANT’s Plans to Revolutionize Crypto… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. BFRI Short Interest - Frequently Asked Questions What is Biofrontera's current short interest? Short interest is the volume of Biofrontera shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 44,000 shares of BFRI short. 1.20% of Biofrontera's shares are currently sold short. Learn More on Biofrontera's current short interest. Which institutional investors are shorting Biofrontera? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Biofrontera: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Biofrontera? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.20% of Biofrontera's floating shares are currently sold short. Is Biofrontera's short interest increasing or decreasing? Biofrontera saw a increase in short interest in April. As of April 15th, there was short interest totaling 44,000 shares, an increase of 26.4% from the previous total of 34,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Biofrontera's float size? Biofrontera currently has issued a total of 5,090,000 shares. Some of Biofrontera's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Biofrontera currently has a public float of 3,670,000 shares. How does Biofrontera's short interest compare to its competitors? 1.20% of Biofrontera's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Biofrontera: NuCana plc (0.50%), Trevena, Inc. (0.33%), Cadrenal Therapeutics, Inc. (2.04%), Virios Therapeutics, Inc. (1.11%), Bionomics Limited (2.03%), Cyclerion Therapeutics, Inc. (1.03%), Vaccinex, Inc. (2.99%), eFFECTOR Therapeutics, Inc. (7.16%), Hepion Pharmaceuticals, Inc. (1.19%), Pasithea Therapeutics Corp. (1.34%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Biofrontera stock? Short selling BFRI is an investing strategy that aims to generate trading profit from Biofrontera as its price is falling. BFRI shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Biofrontera? A short squeeze for Biofrontera occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BFRI, which in turn drives the price of the stock up even further. How often is Biofrontera's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BFRI, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: NuCana Short Interest Data Trevena Short Interest Data Cadrenal Therapeutics Short Interest Data Virios Therapeutics Short Interest Data Bionomics Short Interest Data Cyclerion Therapeutics Short Interest Data Vaccinex Short Interest Data eFFECTOR Therapeutics Short Interest Data Hepion Pharmaceuticals Short Interest Data Pasithea Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BFRI) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithHow Biden has already won 2024Porter & CompanyThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders“Crash Insurance” For Your RetirementUnstoppable ProsperityThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill Publishing